Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, Italy

Background: This article analyzes the main coordination needs linked to the diagnosis and treatment of oncological diseases, presenting the various integration tools that our healthcare organization adopted to guarantee continuity of care at the IRCCS IFO (Istituto di Ricovero e Cura a Carattere Sci...

Full description

Saved in:
Bibliographic Details
Main Authors: Marialuisa Appetecchia, Carlotta Amantea, Marco Canfora, Fabrizio Petrone, Gennaro Ciliberto, Ermete Gallo, Laura Figorilli
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Brain, Behavior, & Immunity - Health
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666354624001972
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586237718822912
author Marialuisa Appetecchia
Carlotta Amantea
Marco Canfora
Fabrizio Petrone
Gennaro Ciliberto
Ermete Gallo
Laura Figorilli
author_facet Marialuisa Appetecchia
Carlotta Amantea
Marco Canfora
Fabrizio Petrone
Gennaro Ciliberto
Ermete Gallo
Laura Figorilli
author_sort Marialuisa Appetecchia
collection DOAJ
description Background: This article analyzes the main coordination needs linked to the diagnosis and treatment of oncological diseases, presenting the various integration tools that our healthcare organization adopted to guarantee continuity of care at the IRCCS IFO (Istituto di Ricovero e Cura a Carattere Scientifico Istituti Fisioterapici Ospitalieri) in Rome. The object of investigation is the disease management team (DMT) organization for the diagnosis and treatment of people suffering from oncological disease and the consequences in terms of improving their management. Methods: The study focuses, in particular, on the analysis of the different organizational methods chosen for the management of activities related to diagnosis and treatment paths. Results: The results, although preliminary, highlight a great variability in the adoption of integrated organizational models by the different DMTs compatible with the heterogeneity of oncological diseases. Conclusion: The results of this study have highlighted that, despite the diversity of the different DMTs created for different oncological pathologies, DMTs guarantee a patient-centered approach and the creation of shared databases, which facilitates the evaluation of progress and the identification of areas for improvement. This analysis has allowed us to obtain a useful map of the models used by the different DMTs, also laying the foundations for more precise evaluations of their effectiveness. The correct evaluation of the effectiveness of DMTs acquires great importance today, especially if we consider that empirical evidence is not yet in agreement on the real effectiveness of this tool with respect to both the qualitative dimension and the efficiency of interventions.
format Article
id doaj-art-f969fbfe7f994c6f93e2d50fe1ece74d
institution Kabale University
issn 2666-3546
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Brain, Behavior, & Immunity - Health
spelling doaj-art-f969fbfe7f994c6f93e2d50fe1ece74d2025-01-26T05:05:00ZengElsevierBrain, Behavior, & Immunity - Health2666-35462025-02-0143100919Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, ItalyMarialuisa Appetecchia0Carlotta Amantea1Marco Canfora2Fabrizio Petrone3Gennaro Ciliberto4Ermete Gallo5Laura Figorilli6Oncological Endocrinology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Italy; Corresponding author. Oncological Endocrinology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Italy.Department of Health Science and Public Health, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168, Rome, ItalyScientific Direction, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Rome, ItalyNursing, Technical, Rehabilitation, Assistance and Research Direction, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Rome, ItalyScientific Direction, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Rome, ItalyCorporate Health Direction, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Rome, ItalyGeneral Direction, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Rome, ItalyBackground: This article analyzes the main coordination needs linked to the diagnosis and treatment of oncological diseases, presenting the various integration tools that our healthcare organization adopted to guarantee continuity of care at the IRCCS IFO (Istituto di Ricovero e Cura a Carattere Scientifico Istituti Fisioterapici Ospitalieri) in Rome. The object of investigation is the disease management team (DMT) organization for the diagnosis and treatment of people suffering from oncological disease and the consequences in terms of improving their management. Methods: The study focuses, in particular, on the analysis of the different organizational methods chosen for the management of activities related to diagnosis and treatment paths. Results: The results, although preliminary, highlight a great variability in the adoption of integrated organizational models by the different DMTs compatible with the heterogeneity of oncological diseases. Conclusion: The results of this study have highlighted that, despite the diversity of the different DMTs created for different oncological pathologies, DMTs guarantee a patient-centered approach and the creation of shared databases, which facilitates the evaluation of progress and the identification of areas for improvement. This analysis has allowed us to obtain a useful map of the models used by the different DMTs, also laying the foundations for more precise evaluations of their effectiveness. The correct evaluation of the effectiveness of DMTs acquires great importance today, especially if we consider that empirical evidence is not yet in agreement on the real effectiveness of this tool with respect to both the qualitative dimension and the efficiency of interventions.http://www.sciencedirect.com/science/article/pii/S2666354624001972Disease management teamOncological diseasesHealthcare organization
spellingShingle Marialuisa Appetecchia
Carlotta Amantea
Marco Canfora
Fabrizio Petrone
Gennaro Ciliberto
Ermete Gallo
Laura Figorilli
Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, Italy
Brain, Behavior, & Immunity - Health
Disease management team
Oncological diseases
Healthcare organization
title Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, Italy
title_full Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, Italy
title_fullStr Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, Italy
title_full_unstemmed Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, Italy
title_short Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, Italy
title_sort disease management teams in oncology state of the art and the experience of a scientific institute of hospitalization and treatment irccs in rome italy
topic Disease management team
Oncological diseases
Healthcare organization
url http://www.sciencedirect.com/science/article/pii/S2666354624001972
work_keys_str_mv AT marialuisaappetecchia diseasemanagementteamsinoncologystateoftheartandtheexperienceofascientificinstituteofhospitalizationandtreatmentirccsinromeitaly
AT carlottaamantea diseasemanagementteamsinoncologystateoftheartandtheexperienceofascientificinstituteofhospitalizationandtreatmentirccsinromeitaly
AT marcocanfora diseasemanagementteamsinoncologystateoftheartandtheexperienceofascientificinstituteofhospitalizationandtreatmentirccsinromeitaly
AT fabriziopetrone diseasemanagementteamsinoncologystateoftheartandtheexperienceofascientificinstituteofhospitalizationandtreatmentirccsinromeitaly
AT gennarociliberto diseasemanagementteamsinoncologystateoftheartandtheexperienceofascientificinstituteofhospitalizationandtreatmentirccsinromeitaly
AT ermetegallo diseasemanagementteamsinoncologystateoftheartandtheexperienceofascientificinstituteofhospitalizationandtreatmentirccsinromeitaly
AT laurafigorilli diseasemanagementteamsinoncologystateoftheartandtheexperienceofascientificinstituteofhospitalizationandtreatmentirccsinromeitaly